Press

20/20 GeneSystems, Inc. Ranks No. 770 on the 2021 Inc. 5000, With Three-Year Revenue Growth of 640 Percent

Inc. magazine today revealed that 20/20 GeneSystems, Inc. is No. 770 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies

Read More

 

County-Based Businesses Recognized For COVID-19 Relief Efforts

These Montgomery County-based companies are being recognized by the state for their contributions to COVID-19 relief efforts.

Read More

 

 

Maryland Legislators Urge More Aggressive Use of Antibody Tests as Local Company Aims to Advance Research

Maryland Department of Health partners with 13 hospitals to launch antibody study

Read More

Only on 7: Can antibody blood tests confirm you’re immune, get you out of quarantine?

Dr. Michael Ross is on the company’s board. He says, “the beauty of it is if you have IgG, the assumption is at that point that you are protected, you’ve been exposed, i.e., you can go back to work; i.e. you can visit your grandmother.”

Read More

 

These Md. companies are racing to create coronavirus testing supplies

Read More

 

These 17 Maryland biotech companies are collaborating in the fight against COVID-19

As more cases of COVID-19 are being reported and leaders seek tests and treatments, biotech companies are stepping up efforts to develop new tests and treatments.

Read More

 

20/20 takes orders for 1st POC fingerstick COVID-19 test

BioResponse is now accepting orders for its point-of-care (POC) fingerstick blood sample rapid COVID-19 test kit

Read More

 

20/20 Launching First COVID-19 Rapid Antibody Test Authorized by FDA for Point-of-Care Use

20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc., announced today that it is now accepting orders for the Assure COVID-19 IgG/IgM Rapid Test kits.

Read More

 

20/20 launching first COVID-19 rapid antibody test authorized by FDA

20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc., announced today that it is now accepting orders for the Assure COVID-19 IgG/IgM Rapid Test kits. These kits were the first to receive an emergency use authorization (EUA) from the FDA for point-of-care (POC) use with fingerstick blood samples on September 23. According to the FDA

Read More

 

 

 

Contact Us

We want to hear from you. Please complete the form below and we will get back to you as soon as possible.

For inquiries: 240-453-6339